Interviews
News Flash
Novozymes to set up new R&D centre in Denmark
05 Jun '15
3 min read
Novozymes has acquired a 140,000 square metre site in Lyngby, located 13 kilometers north of Copenhagen to build a new campus dedicated to research and business development.
“This is an investment in the future, where the new innovation campus will be a cornerstone for our global research,” Per Falholt, executive vice president for R&D at Novozymes said.
“Novozymes is driven by innovation and this center will help strengthen our growth through developing ground-breaking biotechnology,” he added.
Approximately 14 per cent of Novozymes’ revenue is reinvested into research annually, leading to the development of over 100 new products since the company went public 15 years ago.
“These products are used globally and enable energy-efficient production, replacement of fossil fuels, more sustainable food production and other benefits,” it said in a press release.
“Our new campus will be important in creating the ultimate conditions for product development while simultaneously offering our employees a great workplace,” Per Falholt informed.
As part of the campus construction, Novozymes will also establish a learning centre where students and visitors alike are invited to discover and learn about the magic of nature and biology.
The learning centre will include teaching laboratories, a small cinema and a cafe, and will function as a link to the research environment in Lyngby.
More than 20 per cent of Novozymes’ 6,500 employees work within research and development an in Denmark alone, Novozymes employs 2,700 people.
“Novozymes’ project is ambitious and fits perfectly into our goal of developing as a knowledge and University city,” said Sofia Osmani, mayor of Lyngby-Taarbæk, where Novozymes is setting up the centre.
“The new innovation campus will strengthen education, research and business in the municipality and Novozymes also shares our aim to maintain and develop the area as a green recreational oasis,” she added.
The inauguration of the new innovation campus is expected to take place in 2018 upon the approval of the district plan.
Novozymes’ investment in the new innovation campus is included in the company’s previously announced long-term capex guidance.
Capex is expected at around 8 per cent of turnover on average in the period up to and including 2020.
With the new campus, Novozymes will have room for the expected growth in the number of employees in Denmark until after 2020, and units from Bagsværd will move to the new site in Lyngby once it is established.
In accordance with the 2015 financial outlook, Novozymes still expects net investments of around DKK 1 billion in 2015.
Novozymes will run the learning centre which will beopen for pupils, students and other visitors to learn about biology and nature. (AR)
“This is an investment in the future, where the new innovation campus will be a cornerstone for our global research,” Per Falholt, executive vice president for R&D at Novozymes said.
“Novozymes is driven by innovation and this center will help strengthen our growth through developing ground-breaking biotechnology,” he added.
Approximately 14 per cent of Novozymes’ revenue is reinvested into research annually, leading to the development of over 100 new products since the company went public 15 years ago.
“These products are used globally and enable energy-efficient production, replacement of fossil fuels, more sustainable food production and other benefits,” it said in a press release.
“Our new campus will be important in creating the ultimate conditions for product development while simultaneously offering our employees a great workplace,” Per Falholt informed.
As part of the campus construction, Novozymes will also establish a learning centre where students and visitors alike are invited to discover and learn about the magic of nature and biology.
The learning centre will include teaching laboratories, a small cinema and a cafe, and will function as a link to the research environment in Lyngby.
More than 20 per cent of Novozymes’ 6,500 employees work within research and development an in Denmark alone, Novozymes employs 2,700 people.
“Novozymes’ project is ambitious and fits perfectly into our goal of developing as a knowledge and University city,” said Sofia Osmani, mayor of Lyngby-Taarbæk, where Novozymes is setting up the centre.
“The new innovation campus will strengthen education, research and business in the municipality and Novozymes also shares our aim to maintain and develop the area as a green recreational oasis,” she added.
The inauguration of the new innovation campus is expected to take place in 2018 upon the approval of the district plan.
Novozymes’ investment in the new innovation campus is included in the company’s previously announced long-term capex guidance.
Capex is expected at around 8 per cent of turnover on average in the period up to and including 2020.
With the new campus, Novozymes will have room for the expected growth in the number of employees in Denmark until after 2020, and units from Bagsværd will move to the new site in Lyngby once it is established.
In accordance with the 2015 financial outlook, Novozymes still expects net investments of around DKK 1 billion in 2015.
Novozymes will run the learning centre which will beopen for pupils, students and other visitors to learn about biology and nature. (AR)
Fibre2fashion News Desk - India
Popular News
Leave your Comments
Editor’s Pick
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
